|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn876592768 |
003 |
OCoLC |
005 |
20231120111550.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140414s1986 flua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OCLCE
|d OCLCF
|d OCLCO
|d IDEBK
|d OPELS
|d YDXCP
|d E7B
|d OCLCQ
|d EBLCP
|d DEBSZ
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d UKAHL
|d OCLCQ
|d LUN
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 566216340
|a 607863360
|a 655560092
|a 877769411
|a 880437657
|a 974615733
|a 974662374
|a 1100847669
|
020 |
|
|
|a 9781483276397
|q (electronic bk.)
|
020 |
|
|
|a 1483276392
|q (electronic bk.)
|
020 |
|
|
|z 0125976402
|
020 |
|
|
|z 9780125976404
|
035 |
|
|
|a (OCoLC)876592768
|z (OCoLC)566216340
|z (OCoLC)607863360
|z (OCoLC)655560092
|z (OCoLC)877769411
|z (OCoLC)880437657
|z (OCoLC)974615733
|z (OCoLC)974662374
|z (OCoLC)1100847669
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QR185.8.C6
|b I46 1986eb
|
060 |
|
4 |
|a QW 680
|b I33 1986
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.07/9
|2 22
|
084 |
|
|
|a 42.13
|2 bcl
|
084 |
|
|
|a 44.45
|2 bcl
|
245 |
0 |
0 |
|a Immunobiology of the complement system :
|b an introduction for research and clinical medicine /
|c edited by Gordon D. Ross.
|
264 |
|
1 |
|a Orlando :
|b Academic Press,
|c [1986]
|
264 |
|
4 |
|c �1986
|
300 |
|
|
|a 1 online resource (xi, 273 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
520 |
|
|
|a Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine provides an introduction to the complement system. The intention was to create a primer that would provide the basic knowledge of complement required for either research or clinical medicine in diseases involving the complement system.
|
505 |
0 |
|
|a Front Cover; Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine; Copyright Page; Table of Contents; Preface; Introduction and History of Complement Research; I. THE COMPLEMENT SYSTEM; II. HISTORY OF RESEARCH ON COMPLEMENT; III. ROLE OF COMPLEMENT IN INFECTIONS ANDAUTOIMMUNE DISEASE; REFERENCES OF HISTORICAL INTEREST; Chapter 1. The Classical Pathway; I. INTRODUCTION; II. ACTIVATION CASCADE; III. REGULATORY FACTORS; IV. SUMMARY OF AMPLIFICATION FACTORS; REFERENCES; Chapter 2. The Alternative Pathway; I. INTRODUCTION; II. THE PROTEINS.
|
505 |
8 |
|
|a III. THE ACTIVATION PROCESSIV. REGULATION OF ALTERNATIVE PATHWAYACTIVATION BY MEMBRANE-ASSOCIATED PROTEINS; V. BIOLOGICAL EFFECTS OF ALTERNATIVEPATHWAY ACTIVATION; REFERENCES; Chapter 3. Complement Mediatorsof Inflammation; I. INTRODUCTION; II. PRODUCTION OF THE ANAPHYLATOXINS; III. CONTROL MECHANISMS; IV. PHYSIOCHEMICAL CHARACTERIZATION OF THEHUMAN ANAPHYLATOXINS; V. BIOLOGICAL ACTIVITIES OF THE ANAPHYLATOX�INS; VI. THE C5a RECEPTOR; VII. SUMMARY; REFERENCES; Chapter 4. Opsonization and MembraneComplement Receptors; I. INTRODUCTION; II. OPSONIZATION; III. MEMBRANE COMPLEMENT RECEPTORS.
|
505 |
8 |
|
|a IV. METHODS FOR DIRECTION OF OPSONIC COMPLEMENT FRAGMENTS AND COMPLEMENTRECEPTORSREFERENCES; Chapter 5. Assembly and Functions of the Terminal Components; I. INTRODUCTION; II. ASSEMBLY OF THE MAC; III. FUNCTIONAL EFFECTS OF THE MACON TARGET MEMBRANES; IV. ESCAPE MECHANISMS FROM MAC ATTACK; V. PATHOPHYSIOLOGICAL SIGNIFICANCE OF THEMEMBRANE ATTACK SEQUENCE; VI. PROTECTION OF HOST CELLS FROM ATTACKBY MAC; VII. PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 6.Complement-Dependent Mechanisms of Virus Neutralization; I. INTRODUCTION; II. IMMUNITY TO VIRUSES AND VIRUS-INFECTED CELLS.
|
505 |
8 |
|
|a III. COMPLEMENT ACTIVATION BY VIRUSES ANDVIRUS-INFECTED CELLSIV. ANTIBODY- AND COMPLEMENT-DEPENDENT VIRALNEUTRALIZATION; V. EFFECTS OF ANTIBODY AND COMPLEMENT ONVIRUS-INFECTED CELLS; VI. CONCLUSIONS; REFERENCES; Chapter 7. Genetics and Synthesis of Components of the ComplementSystem; I. INTRODUCTION; II. GENETIC VARIANTS: POLYMORPHISM OF THECOMPLEMENT PROTEINS; III. STRUCTURE AND ORGANIZATION OFCOMPLEMENT GENES; IV. EXPRESSION OF COMPLEMENT GENES; V. COMPLEMENT DEFICIENCIES; VI. CONCLUSIONS; REFERENCES; Chapter 8. Role of Complement inInfectious Diseases; I. INTRODUCTION.
|
505 |
8 |
|
|a II. MICROBIAL ANTIGENS CAPABLEOF ACTIVATING COMPLEMENTIII. LOCALIZATION OF ANTIBODY AND COMPLEMENTCOMPONENTS ON MICROORGANISMS; IV. COMPLEMENT-MEDIATED LYSIS OF BACTERIA; V. ROLE OF ANTIBODY AND COMPLEMENT IN BLOODSTREAMCLEARANCE OF MICROORGANISMS; VI. NONCOMPLEMENT AND NONANTIBODY FACTORSINTERACTING WITH COMPLEMENT IN HOST DEFENSE; VII. ROLE OF COMPLEMENT IN THE PATHOGENESISOF INFECTIOUS DISEASE; VIII. CONCLUSIONS; REFERENCES; Chapter 9. Complement and the Rheumatic Diseases; I. INTRODUCTION; II. SYSTEMIC LUPUS ERYTHEMATOSUS; III. RHEUMATOID ARTHRITIS ANDRELATED ARTHRITIDES; IV. CRYOGLOBULINS.
|
650 |
|
0 |
|a Complement (Immunology)
|
650 |
|
0 |
|a Complement activation.
|
650 |
|
2 |
|a Complement Activation
|0 (DNLM)D003167
|
650 |
|
2 |
|a Complement System Proteins
|x immunology
|0 (DNLM)D003165Q000276
|
650 |
|
2 |
|a Complement System Proteins
|0 (DNLM)D003165
|
650 |
|
6 |
|a Compl�ement (Immunologie)
|0 (CaQQLa)201-0077142
|
650 |
|
6 |
|a Compl�ement (Immunologie)
|x Activation.
|0 (CaQQLa)201-0236049
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Complement activation
|2 fast
|0 (OCoLC)fst00871564
|
650 |
|
7 |
|a Complement (Immunology)
|2 fast
|0 (OCoLC)fst00871562
|
653 |
|
|
|a Man
|a Blood plasma
|a Complement
|
700 |
1 |
|
|a Ross, Gordon D.
|
776 |
0 |
8 |
|i Print version:
|t Immunobiology of the complement system
|z 0125976402
|w (DLC) 86003398
|w (OCoLC)13328930
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780125976404
|z Texto completo
|